Guideline Development and Committees - AIDS Institute Clinical Guidelines

Expert Committees

Composition: The Clinical Guidelines Program works directly with committees composed of experts in the field who represent multiple disciplines (medicine, nursing, psychology, pharmacy, public health, social work, mental health), clinical specialties (infectious diseases, family medicine, obstetrics and gynecology, hepatology, pediatrics, psychiatry, dentistry, prevention, etc.), and various geographic regions of New York State.

A Clinical Guidelines Program Steering Committee provides oversight and strategy to the following Clinical Guidelines Program committees, each of which is responsible for developing and updating clinical practice guidelines that fall under its area of expertise. Current committees (May 2018) include the following:

Financial disclosure and confidentiality agreement: All potential and active committee members are required to sign a confidentiality agreement and to disclose annually all financial relationships with commercial entities or gifts that may be actual, potential, or perceived as conflicts of interest. Committee members must report financial relationships with commercial entities that have existed in the 12 months prior to or are expected to exist in the 12 months after the date on which they sign their disclosure form.

Guideline development process: When the Clinical Guidelines Program identifies the need to develop or update a guideline, the committee under whose purview the guideline falls convenes to determine the goals of the guideline and its content, review the published literature, and weigh new evidence for recommendations. Text is then drafted by an author who has experience with the topic of the guideline. The guideline draft is edited by the team at JHU, and then reviewed and modified by the committee. This rigorous development process may entail multiple rounds of review, revision, rating and editing. Decision making occurs by consensus, and all guideline recommendations are reviewed by and receive the consensus approval of the full guideline committee.

Evidence-based Recommendations: All recommendations are rated to reflect the strength of each recommendation and the quality of the supporting evidence. Ratings are reached through review of the evidence and consensus decision. If the published evidence in support of a particular recommendation is not sufficient, the group relies on collective best practices experience to develop a final statement. The rating scheme for recommendations appears below.

AIDS Institute Clinical Guidelines Program: Recommendations Ratings (updated June 2019*)
Strength of Recommendation Ratings
A	Strong recommendation
B	Moderate recommendation
C	Optional
Quality of Supporting Evidence Ratings
1	Indicates that the evidence supporting a recommendation is derived from published results of at least one randomized trial with clinical outcomes or validated laboratory endpoints.
*	Indicates that the evidence supporting a recommendation is strong because it is: 1) based on a self-evident conclusion(s); 2) conclusive, published, in vitro data; or 3) well-established, accepted practice that cannot be tested because ethics would preclude a clinical trial.
2	Indicates that the evidence supporting a recommendation is derived from published results of at least one well-designed, nonrandomized clinical trial or observational cohort study with long-term clinical outcomes.
2†	Indicates that the evidence supporting a recommendation has been extrapolated from published results of well-designed studies (including non-randomized clinical trials) conducted in populations other than those specifically addressed by a recommendation. The source(s) of the extrapolated evidence and the rationale for the extrapolation are provided in the guideline text. One example would be results of studies conducted predominantly in a subpopulation (e.g., one gender) that the committee determines to be generalizable to the population under consideration in the guideline.
3	Indicates that a recommendation is based on the expert opinion of the committee members. The rationale for the recommendation is provided in the guideline text.
With the June 2019 update, the ratings for quality of supporting evidence were expanded to add the rating and the 2† rating.

External review: All guidelines are reviewed by external experts in the field and by the AIDS Institute’s Consumer Advisory Committee.

Final approval: The guideline is submitted to the AIDS Institute for review and final approval prior to publication. The AI may request additional review by other agencies and organizations when applicable.

Guideline Updates: Members of guideline committees monitor developments ongoing to maintain guideline currency, at regular intervals. Newly published data that provides support for existing recommendations will be cited in the text and the studies will be added to the reference list. If newly published data prompts a revision to recommendations or rationale, a planning committee proposes appropriate edits and determines whether any changes warrant full committee review and approval.

Medical Care Criteria Committee (MCCC)

The MCCC is responsible for guidelines that address the care of adults with HIV

Updated August 13, 2018

Leadership

Chair: Joseph P. McGowan, MD, FACP, FIDSA
North Shore University Hospital, Manhasset, NY
No disclosures

Vice-Chair: Steven M. Fine, MD, PhD
University of Rochester Medical Center, Rochester, NY
No disclosures

Chair Emeritus: Samuel T. Merrick, MD
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health, AIDS Institute, New York, NY
No disclosures

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members

James C. M. Brust, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

John M. Conry, PharmD, AAHIVP, FNAP
St. John’s University, Queens, NY
No disclosures

Elliot DeHaan, MD
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY
No disclosures

Mary Dyer, MD
Hudson River Healthcare, Monticello, NY
No disclosures

Daniel Egan, MD
Columbia University Vagelos College of Physicians and Surgeons, New York, NY
No disclosures

Jack Fuhrer, MD
Stony Brook University School of Medicine, Stony Brook, NY
No disclosures

Christine A. Kerr, MD
Hudson River HealthCare, Beacon, NY
No disclosures

Jeremy D. Kidd, MD, MPH
New York Presbyterian Hospital, Columbia University, New York, NY
No disclosures

Luz Amarilis Lugo, MD
Mount Sinai Comprehensive Health Program-Downtown, New York, NY
No disclosures

Cynthia H. Miller, MD
Albany Medical Center, Albany, NY
No disclosures

Gene Morse, PharmD, FCCP, BCPS
University at Buffalo School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY
No disclosures

Julie E. Myers, MD, MPH
New York City Department of Health and Mental Hygiene, Queens, NY
No disclosures

Hector Ojeda-Martinez, MD
SUNY Downstate Medical Center, Brooklyn, NY
No disclosures

David C. Perlman, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Asa E. Radix, MD, MPH, FACP, AAHIVS
Callen-Lorde Community Health Center, New York, NY
No disclosures

Sanjiv S. Shah, MD, MPH, AAHIVM, AAHIVS
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Noga Shalev, MD
Columbia University Medical Center, New York, NY
No disclosures

Eugenia L. Siegler, MD
Weill Cornell Medical College, New York, NY
No disclosures

Maria Teresa Timoney, MS, RN, CNM
Bronx Lebanon Hospital Center, Bronx, NY
No disclosures

Marguerite A. Urban, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY
No disclosures

Antonio E. Urbina, MD
Mount Sinai Hospital, New York, NY
Scientific Advisor: Gilead, ViiV, Merck

Rona M. Vail, MD
Callen-Lorde Community Health Center, New York, NY
No disclosures

Geoffrey A. Weinberg, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY
No disclosures

Agency, Consumer, and Program Liaisons

Sheldon T. Brown, MD, James J. Peters Veterans Affairs Medical Center, Bronx, NY
New York State Department of Veterans Affairs Medical Center
No disclosures

Douglas G. Fish, MD, NYSDOH, Albany, NY
New York State Department of Health Office of Health Insurance Programs
No disclosures

Annette Gaudino, TAG, New York, NY
Community Liaison, Treatment Action Group
No disclosures

Carlos Salama, MD, Elmhurst Hospital Center, Elmhurst, NY
New York City Health + Hospitals
No disclosures

Cheryl A. Smith, MD, NYSDOH AIDS Institute, New York, NY
New York State Department of Health AIDS Institute Clinical Education Initiative
No disclosures

William M. Valenti, MD, FIDSA, Trillium Health, Rochester, NY
Medical Society of the State of New York
Financial disclosure: Scientific Advisor, Gilead Sciences

External Contributors and Reviewers

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in adult HIV care. For all guidelines published in 2017 and later, external/peer reviewers are listed in the guideline section “How This Guideline Was Developed.”

Gastrointestinal Complications: Douglas T. Dieterich, MD, Mount Sinai School of Medicine, New York, NY (Peer Reviewer); Michael Poles, MD, New York University Medical Center, New York, NY (Peer Reviewer)

HAV/HIV Co-Infection: Elizabeth Rausch-Phung, MD, MPH, New York State Department of Health, Albany, NY (Peer Reviewer); Daniel Kuhles, MD, New York State Department of Health, Albany, NY (Peer Reviewer)

HIV-2: Grace Y. Minamoto, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Elizabeth R. Jenny-Avital, MD, Jacobi Medical Center, Bronx, NY (Contributor); Lucia V. Torian, PhD, New York City Department of Health and Mental Hygiene, Long Island City, NY (Contributor); Phyllis Kanki, PhD, Harvard School of Public Health, Boston, MA (Peer Reviewer); Monica M. Parker, PhD, Wadsworth Center, NYSDOH, Albany, NY (Peer Reviewer)

HIV Testing (2016): Monica M. Parker, PhD, New York State Department of Health Wadsworth Center, Albany, NY (Peer Reviewer)

Kidney Disease in HIV-Infected Patients: Jonathan A. Winston, MD, Mount Sinai School of Medicine, New York (Contributor); Andy Choi, MD, University of California, San Francisco, CA (Peer Reviewer); Christina M. Wyatt, MD, Mount Sinai School of Medicine, New York (Peer Reviewer)

Menstrual Disorders in HIV-Infected Women: David C Foster, MD, MPH, University of Rochester School of Medicine and Dentistry, Rochester, NY (Contributor); John F.J. Clark, MD, Columbia University Medical Center, New York, NY (Peer Reviewer)

Neurologic Complications: David Simpson, MD, Mount Sinai Medical Center, New York, NY (Contributor); Lydia B. Estanislao, MD, Mount Sinai Medical Center, New York, NY (Contributor); Anthony Geraci, MD, Mount Sinai Medical Center, New York, NY (Contributor); David B. Clifford, MD, Washington University School of Medicine, St. Louis, MO (Peer Reviewer) ; Karl Kieburtz, MD, MPH, University of Rochester Medical Center, Rochester, NY (Peer Reviewer)

Oral Health Complications: Stuart Fischman, DMD, SUNY at Buffalo, Buffalo, NY (Contributor); Georgina Zabos, DDS, MPH, Columbia University School of Dental and Oral Surgery, New York, NY (Peer Reviewer)

PEP Following Non-Occupational Exposure: Daniel J Egan, MD, FACEP, St Luke’s Roosevelt Hospital Center, New York, NY (Peer Reviewer)

PEP Following Occupational Exposure: Yvette Calderon, MD, MS, Jacobi Medical Center, Bronx, NY (Peer Reviewer); Michela T Catalano, MD, Albert Einstein College of Medicine, Bronx, NY (Peer Reviewer); Daniel J Egan, MD, FACEP, St Luke’s Roosevelt Hospital Center, New York, NY (Peer Reviewer)

PEP for Victims of Sexual Assault: Elizabeth Louise Berberian, MPH, New York State Department of Health AIDS Institute, Albany, NY (Contributor); Mary Chris Schultz, BS, New York State Department of Health AIDS Institute, Albany, NY (Contributor)

Perioperative Management: Sian Jones, MD, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY (Contributor); Frances R. Wallach, MD, Mount Sinai School of Medicine, New York, NY (Contributor); Michelle S. Cespedes, MD, New York University School of Medicine, New York, NY (Peer Reviewer); Susan A Olender, MD, Columbia Presbyterian Medical Center, New York, NY (Peer Reviewer)

Primary Care Approach to the Patient with HIV Infection: Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Kinga Cieloszyk, MD, MPH, New York City Department of Health and Mental Hygiene, New York, NY (Contributor); William M. Valenti, MD, University of Rochester School of Medicine and Dentistry, Rochester, NY (Peer Reviewer)

Hepatitis C Virus Infection Guidelines Committee

Updated August 13, 2018

Leadership

Co-Chair: Joshua S. Aron, MD
Elmhurst Hospital Center, Elmhurst, NY
No disclosures

Co-Chair: Christine A. Kerr, MD
Hudson River HealthCare, Beacon, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members

Mary Angerame, MS APN-BC
Jordan Health, Rochester, NY
No disclosures

Ayse Aytaman, MD, AGAF, FACG
Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY
No disclosures

David Bernstein, MD, FAASLD, FACG, AGAF, FACP
Hofstra-Northwell School of Medicine, Manhasset, NY
Scientific Advisor: Abbvie, Gilead

Kristen Marks, MD
Weill Cornell Medical College, New York, NY
No disclosures

Brianna Norton, DO, MPH
Montefiore Medical Group, Bronx, NY
No disclosures

Ponni V. Perumalswami, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Jeffrey J. Weiss, PhD, MS
Mount Sinai School of Medicine, New York, NY
No disclosures

Agency, Consumer, and Program Liaisons

Paula R. Bozer, MD, Wende Correctional Facility, Alden, NY
New York State Department of Corrections and Community Supervision
No disclosures

Douglas G. Fish, MD, NYSDOH, Albany, NY
New York State Department of Health Office of Health Insurance Programs
No disclosures

Colleen Flanigan, RN, MS, NYSDOH AIDS Institute, Albany, NY
Clinical Liaison, New York State Department of Health AIDS Institute Viral Hepatitis Section
No disclosures

Annette Gaudino, TAG, New York, NY
Community Liaison, Treatment Action Group
No disclosures

Vinh Pham, MD, PhD, Bellevue Hospital Center, New York, NY
New York City Health + Hospitals
No disclosures

Cheryl Santoro, Hudson River HealthCare, Peekskill, NY
Consumer Liaison, Hudson River HealthCare
No disclosures

Jessie Schwartz, RN, MPH, NYC DOHMH, Queens, NY
New York City Department of Health and Mental Hygiene
No disclosures

Cheryl A. Smith, MD, NYSDOH AIDS Institute, New York, NY
New York State Department of Health AIDS Institute Clinical Education Initiative
No disclosures

William M. Valenti, MD, FIDSA, Trillium Health, Rochester, NY
Medical Society of the State of New York
Financial disclosure: Scientific Advisor, Gilead Sciences

AIDS Institute HIV Clinical Guidelines Program Committee Reviewers

Medical Care Criteria Committee: Samuel T. Merrick, MD (Chair), New York-Presbyterian Hospital, New York, NY; Joseph P. McGowan, MD, FACP, FIDSA (Vice-Chair), Northwell Health, Manhasset, NY; Judith A. Aberg, MD, FIDSA, FACP (Chair Emeritus), Icahn School of Medicine at Mount Sinai, New York, NY
Committee for the Prevention of Mother to Child Transmission of HIV: Rodney L. Wright, MD, MS (Co-Chair), Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

EXTERNAL PEER REVIEWERS

Douglas T. Dieterich, MD, Icahn School of Medicine at Mount Sinai, New York, NY
Ira M. Jacobson, MD, Mount Sinai Beth Israel, New York, NY
Oluwaseun Falade-Nwulia, MBBS, MPH, Johns Hopkins University School of Medicine, Baltimore, MD
Karla Thorton, MD, University of New Mexico School of Medicine, Albuquerque, NM

*These individuals participated in the early development of the HCV guideline but were no longer in their positions, or were not able to serve as liaisons at the conclusion of the project.

Perinatal Transmission Prevention Guideline Committee

2014-to date; updated July 24, 2018

Leadership

Co-Chair: Rodney L. Wright, MD, MS
Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

Co-Chair: Murli Purswani, MBChB, FAAP
Bronx-Lebanon Hospital Center, Bronx, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Deputy Medical Director: Lyn Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

Contributing Members and Liaisons

Lan L. Adams, MD, MPH
Women and Children’s Hospital of Buffalo, Buffalo, NY

David A. Baker, MD
Stony Brook School of Medicine, Stony Brook, NY

Keith A. Eddleman, MD
Ichan School of Medicine at Mount Sinai, New York, NY

Gary S. Eglinton, MD
New York Hospital Queens, Flushing, NY

Marc D. Foca, MD
Children’s Hospital of New York, New York, NY

Mahmoud M. Hassanein, MD
Brookdale University Hospital, Brooklyn, NY

Angela D. Kerr, MD
Brooklyn Hospital Center, Brooklyn, NY

Howard L. Minkoff, MD, FACOG
Maimonides Medical Center, Brooklyn, NY

David Rosenthal, DO, PhD
North Shore-LIJ Medical Group, Great Neck, NY

Renee Samelson, MD, MPH
Albany Medical Center, Albany, NY

Roberto P. Santos, MD, MSCS
Albany Medical Center, Albany, NY

Maria Teresa Timoney, CNM
Bronx Lebanon Hospital Center, Bronx, NY

Geoffrey A. Weinberg, MD, FAAP, FIDSA
University of Rochester School of Medicine and Dentistry, Golisano Children’s Hospital, Rochester, NY

Leonard B. Weiner, MD
SUNY Upstate Medical University, Syracuse, NY

Andrew A. Wiznia, MD
Jacobi Medical Center, Bronx, NY

NYSDOH AIDS Institute Liaison

Suzanne Kaufman, MPH, BSN, RN, AACRN, Albany, NY
Perinatal HIV Prevention Program

External Contributors and Reviewers

Acute HIV Infection in Pregnancy: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor)

Care of the HIV-Exposed Infant with Indeterminate Status: Murli U Purswani, MBChB, FAAP, Bronx-Lebanon Hospital Center, Bronx, NY(Peer Reviewer); Joseph S Cervia, MD, MBA, FACP, FAAP, FIDSA, AAHIVS, Hofstra North Shore, Long Island Jewish School of Medicine, Hempstead, NY (Peer Reviewer); Roberto P Santos, MD, MSc, Albany Medical Center, Albany, NY (Peer Reviewer)

Diagnosis of Pediatric HIV Infection in HIV-Exposed Infants: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor); Roberto Posada, MD, Mount Sinai Hospital, NY (Contributor)

HIV Testing During Pregnancy and at Delivery: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor)

Preconception Care for HIV-Infected Women: Katherine D. LaGuardia, MD, MPH, FACOG, Ortho-McNeil Pharmaceutical, Inc., Raritan, NJ (Contributor); Katherine T. Chen, MD, MPH, Columbia University, New York, NY (Peer Reviewer); Roberta A. Stewart, MPH, Bureau of Special Populations, Prevention Division of the AIDS Institute, New York State Department of Health, New York, NY (Peer Reviewer)

Sexually Transmitted Infections Guidelines Committee

2016-to date

Leadership

Chair: Marguerite A. Urban, MD
University of Rochester Medical Center, Rochester, NY

Vice-Chair: Michael H. Augenbraun, MD, FACP, FIDSA
SUNY Downstate, Brooklyn, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Deputy Medical Director: Lyn Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

Contributing Members and Liaisons

Elizabeth Asiago-Reddy, MD
SUNY Upstate, Syracuse, NY

Gale R. Burstein, MD, MPH, FAAP
Erie County Department of Health, Buffalo, NY

Michael M. Gaisa, PhD, MD
Mount Sinai, New York, NY

Shelley Gilroy, MD
Albany Medical College, Albany, NY

Sachin Jain, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Marla J. Keller, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Anita P. LaSala, MD
Columbia University Medical Center, New York, NY

Robert Murayama, MD, MPH, AAHIVM, FACP
The Institute for Family Health, New York, NY

Michel Ng, NP
Mount Sinai School of Medicine, New York, NY

Thomas Panzella, PAC
HEAT/Downstate, Brooklyn, NY

Asa Radix, MD, MPH, FACP, AAHIVS
Callen-Lorde Community Health Center, New York, NY

David W. Rosenthal, DO, PhD
Northwell Health Physician Partners, Great Neck, NY

Heather M. Territo, MD
University at Buffalo-SUNY, Buffalo, NY

Agency, Consumer, and Program Liaisons

Bisrat K. Abraham, MD, NYC DOHMH, Long Island City, NY
New York City Department of Health and Mental Hygiene

Beatrice Aladin, MD, MPH, NYSDOH AI, New York, NY
New York State Department of Health AIDS Institute Clinical Education Initiative

Richard Greene, MD, FACP, FIDSA, New York, NY
New York City Health + Hospitals

David Martin, New York, NY
New York State Department of Health AIDS Institute Consumer Advisory Committee

Tarek Mikati, MD, MPH, NYC DOHMH, Long Island City, NY
New York City Department of Health and Mental Hygiene

External Contributors and Reviewers

Bacterial Vaginosis: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Susan Blank, MD, MPH, and Kristen Harvey, MD, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Chancroid: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); Kristen Harvey, MD, Bureau of STD Control, NYC DOHMH, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Genital Herpes Simplex Virus (HSV): Barry S. Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Gonococcal and Chlamydial Infections: Douglas G. Fish, MD, Albany Medical College, Albany, NY (Contributor); Jessica E. Justman, MD, Columbia University, New York, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Human Papillomavirus (HPV): Gina M. Brown, MD, New York City Department of Health, New York, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Lymphogranuloma Venereum (LGV): F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Syphilis: Barry S Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Judith A Aberg, MD, New York University School of Medicine, New York, NY (Contributor); Eunmee H. Chun, MD, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer)

Trichomoniasis: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Gina M Brown, MD, National Institutes of Health, Office of AIDS Research, Bethesda, MD (Contributor); Eunmee H. Chun, MD, MPH, Bureau of STD Prevention and Control, New York City Department of Health and Mental Hygiene, Long Island City, NY (Peer Reviewer); Demetre C Daskalakis, MD, Bellevue Hospital, NYU Langone Medical Center, New York, NY (Peer Reviewer)

Substance Use Guidelines Committee

2016-to date; updated August 13, 2018

Leadership

Chair: Chinazo O. Cunningham, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Vice-Chair: Kelly S. Ramsey, MD, MPH, MA, FACP
Hudson River HealthCare, Poughkeepsie, NY
No disclosures

Consulting Expert: Sharon L. Stancliff, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members

Marcus Bachhuber, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Michael L. Christie, MD
University of Rochester Medical Center, Rochester, NY
No disclosures

Angela G. Giovanniello, PharmD, AAHIVP
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Raymond Harvey, MD
Institute for Family Health, Kingston, NY
No disclosures

Giliane Joseph, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Shadi Nahvi, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

David C. Perlman, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Susan D. Whitley, MD
New York City Health + Hospitals/Kings County, Brooklyn, NY
No disclosures

Timothy J. Wiegand, MD
University of Rochester Medical Center, Rochester, NY
Consultant: McKesson Corporation

Agency, Consumer, and Program Liaisons

Narelle Ellendon, RN, NYSDOH AIDS Institute, New York, NY
New York State Department of Health AIDS Institute
No disclosures

Annette Gaudino, TAG, New York, NY
Community Liaison, Treatment Action Group
No disclosures

Hillary Kunins, MD, MPH, MS, NYC DOHMH, Queens, NY
New York City Department of Health and Mental Hygiene
No disclosures

External Contributors and Peer Reviewers

Adherence to Antiretroviral Therapy Among Substance Users: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Contributor); David Bangsberg, MD, MPH, University of California, San Francisco, CA (Peer Reviewer); Lois Eldred, DrPH, Health Resources and Services Administration, HIV/AIDS Bureau, Rockville, MD (Peer Reviewer)

Aspects of Primary Care for the HIV-Infected Substance User: David C Perlman, MD, Beth Israel Medical Center, and National Development and Research Institutes, New York, and Albert Einstein College of Medicine, Bronx, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Vladimir Poznyak, MD, PhD, World Health Organization (Peer Reviewer); Jeffrey Samet, MD, MA, MPH, Boston University School of Medicine, Boston, MA (Peer Reviewer)

Care of the Hospitalized HIV-Infected Substance User: Brenda Chabon, PhD, Montefiore Medical Center, Bronx, NY (Contributor); Eunmee H. Chun, MD, New York State Department of Health AIDS Institute, New York, NY (Contributor); Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Sheree Starrett, MD, Casa Promesa, Bronx, NY (Peer Reviewer); Stanley R. Yancovitz MD, Beth Israel Medical Center, New York, NY (Peer Reviewer)

Clinical Management of Alcohol Use and Abuse in HIV-Infected Patients: Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh, PA (Contributor); Thomas Kresina, PhD, National Institute on Drug Abuse, Bethesda, MD (Peer Reviewer); Richard Saitz, MD, MPH, Boston University School of Medicine, Boston, MA (Peer Reviewer)

Drug-Drug Interactions Between ARV Agents, Medications Used in Substance Use Treatment, and Recreational Drugs: John J. Faragon, PharmD, Albany Medical Center, Albany, NY (Contributor); Paul Pham, PharmD, The Johns Hopkins University, Baltimore, MD (Contributor); Elinore F. McCance-Katz, MD, PhD, Virginia Commonwealth University, Richmond, VA (Peer Reviewer)

Medical Care of HIV-Infected Substance-Using Women: Diane M. Rudnick, MEd, New York State Department of Health AIDS Institute, New York, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Hillary Kunins, MD, MPH, Montefiore Medical Center, Bronx, NY (Peer Reviewer); Barbara C. Zeller, MD, Project Samaritan AIDS Services, Bronx, NY (Peer Reviewer)

Mental Health Disorders Among Substance-Using HIV-Infected Patients: Steven L Batki, MD, SUNY Upstate Medical University, Syracuse, NY (Contributor); John AR Grimaldi, Jr, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY (Contributor); Marshall Forstein, MD, The Cambridge Hospital, Cambridge, MA (Peer Reviewer); George E. Woody, MD, University of Pennsylvania, and the Philadelphia VA Medical Center, Philadelphia, PA (Peer Reviewer)

Pain in the HIV-Infected Substance User: Robert B. Whitney, MD, Erie County Medical Center, Buffalo, NY; William S. Breitbart, MD, Memorial Sloan-Kettering Cancer Center, New York, NY (Peer Reviewer); Andrew Rosenblum, PhD, National Development and Research Institutes, New York, NY (Peer Reviewer)

Screening and Ongoing Assessment for Substance Use; Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Thomas F. Babor, PhD, MPH, The Alcohol Research Center at the University of Connecticut School of Medicine, Farmington, CT (Peer Reviewer); Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh, PA (Peer Reviewer)

Smoking Cessation in HIV-Infected Patients: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Contributor); Alvaro Carrascal, MD, MPH, New York State Department of Health, Albany, NY (Peer Reviewer); Kimber P. Richter, PhD, MPH, University of Kansas Medical Center, Kansas City, KS (Peer Reviewer)

Substance Use Treatment Modalities for HIV-Infected Substance Users: Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Marc N. Gourevitch, MD, MPH, New York University School of Medicine, New York, NY (Contributor); Jeffrey Rothman, New York State Department of Health AIDS Institute, New York (Contributor); Deborah Brotman, MD, Center For Comprehensive Health Practice, New York, NY (Peer Reviewer)

What Are These Drugs? Steven S Kipnis, MD, FACP, FASAM, New York State Office of Alcoholism and Substance Abuse Services, Orangeburg, and Albany Medical College, Albany, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor)

Working With the Active User: Nancy Murphy, NP, St Luke’s Roosevelt Hospital Center, and CUNY Graduate Center, New York, NY (Contributor); Robert B. Whitney, MD, Erie County Medical Center, Buffalo (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Kumara Singaravelu, MBBS, MPH, New York County Health Services Review Organization, New York, NY (Peer Reviewer)

Dental Standards of Care Committee

2012-to date

Leadership

Chair: Stephen N. Abel, DDS, MSD
University at Buffalo-SUNY, Buffalo, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health, AIDS Institute, New York, NY

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
Office of the Medical Director, New York State Department of Health AIDS Institute, Albany, NY

JHU Principal Investigator: Christopher J. Hoffmann, MD
Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

Victor M. Badner, DMD, MPH
North Bronx Healthcare Network, Bronx, NY

Mary Therese Biltucci, RDH, MA
University of Rochester, Rochester, NY

Stanley J. Boyd, DMD
Healthy Chelsea Dentistry, New York, NY

Gwen Cohen Brown, DDS, FAAOMP
New York City College of Technology, Brooklyn, NY

Dolores Cottrell-Carson, DDS, MSHA
New York State Board for Dentistry, Albany, NY

Maria de los Angeles Figueroa, DMD
Bronx-Lebanon Hospital Center, Bronx, NY

Mary J. D’Silva, DDS
NYS DOC and Community Supervision, Albany, NY

Robert D. Kelsch, DMD
Northwell Health, Manhasset, NY

Michael A. Kozlowski, DDS
Unity Dental Group, Rochester, NY

Kareem J. Merrick, DDS
Harlem United Community Clinic, New York, NY

Calix Ramos-Rodriguez, DMD
Lutheran Medical Center, Brooklyn, NY

Miriam R. Robbins, DDS, MS
Winthrop University Hospital, Mineola, NY

Dara J. Rosenberg, DDS, MS, MPH
St. Barnabas Hospital, Bronx, NY

Terrence T. Thines, DDS, MS
SUNY Upstate Medical University, Syracuse, NY

Agency, Consumer, and Program Liaisons

Britta Viereckl-Prast, DMD
New York State Department of Corrections and Community Supervision, Bedford Hills, NY

Jahlove Serrano
New York State Department of Health AIDS Institute Consumer Advisory Committee, Bronx, NY

David Martin
New York State Department of Health AIDS Institute Consumer Advisory Committee, New York, NY

External Contributors and Reviewers

Clinical Manifestations and Management of HIV-Related Periodontal Disease: Barbara Gerbert, PhD, University of California School of Dentistry, San Francisco, CA (Peer Reviewer)

Diagnosis and Management of Soft-Tissue Lesions: Stuart L Fischman, DMD, State University of New York, Buffalo, NY (Contributor); Michael Glick, DMD, University of Pennsylvania School of Dental Medicine, Philadelphia, PA (Peer Reviewer)

General Principles: Georgina P. Zabos, DDS, MPH, Columbia University School of Dental and Oral Surgery, New York, NY (Contributor); Amneris E. Luque, MD, Strong Memorial Hospital, Rochester, NY (Peer Reviewer); Barbara H. Chaffee, MD, MPH, Binghamton Family Care Center, United Health Services Hospital, Binghamton, NY (Peer Reviewer); Marc N. Gourevitch, MD, MPH, New York University School of Medicine, New York, NY (Peer Reviewer)

HIV Testing in the Oral Healthcare Setting: Joan A. Phelan, DDS, New York University College of Dentistry, New York, NY (Peer Reviewer); Michael Hatton, DDS, University at Buffalo, Buffalo, NY (Peer Reviewer)

Infection Control: Helene Bednarsh, RDH, MPH, HIV Dental at Boston Public Health Commission, Boston, MA (Peer Reviewer)

Oral and Maxillofacial Surgery: David Drohan, DDS, Albany Medical College, Division of Dentistry, Albany, NY (Contributor); Paul E Gates, DDS, MBA, Bronx-Lebanon Hospital Center, Bronx, NY (Contributor); Robert S Glickman, DMD, New York University College of Dentistry, New York, NY (Peer Reviewer)